Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

683
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
683
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

254
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
254
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

805
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
805
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

499
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
499
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

76
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
76

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semaglutide for Primary Prevention of Major Adverse Cardiac and Cerebrovascular Events in Patients with Type 2 Diabetes and Comorbid Rheumatoid Arthritis: A Target-Trial Emulation.

European heart journal. Cardiovascular pharmacotherapy·2026
Same author

Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease: Shared Mechanisms and Therapeutic Opportunities.

Cardiology in review·2026
Same author

Case Report: Management of intracranial hypertension in acute-on-chronic liver failure: a case of fulminant cerebral edema and acute-onset severe hyperammonemia in a patient with cirrhosis.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026
Same author

Statins in Gastroenterology: Mechanisms, Human Evidence, and Safety.

Cardiology in review·2026
Same author

Changing Trends in Bladder Cancer Epidemiology in the Israeli Population: 1996-2016.

The Israel Medical Association journal : IMAJ·2025
Same author

The Impact of Cirrhosis Severity and Spironolactone on Sex Hormone Levels in Men.

Gastro hep advances·2025

Related Experiment Video

Updated: May 21, 2025

Human Skeletal Muscle Biopsy Procedures Using the Modified Bergström Technique
07:20

Human Skeletal Muscle Biopsy Procedures Using the Modified Bergström Technique

Published on: September 10, 2014

39.9K

Lean MASLD and Cardiovascular Disease: A Review.

Nachum Lebovics1, Gabriel Heering2, William H Frishman2

  • 1From the Department of Medicine, NYC Health & Hospitals/Jacobi Medical Center, New York, NY.

Cardiology in Review
|March 21, 2025
PubMed
Summary

Lean Metabolic-associated steatotic liver disease (MASLD) poses a significant cardiovascular risk, even in individuals with a healthy weight. This review explores its unique pathophysiology and discusses management strategies for better patient outcomes.

More Related Videos

A Guide to Examining Intramuscular Fat Formation and its Cellular Origin in Skeletal Muscle
09:19

A Guide to Examining Intramuscular Fat Formation and its Cellular Origin in Skeletal Muscle

Published on: May 26, 2022

3.8K
Human Vastus Lateralis Skeletal Muscle Biopsy Using the Weil-Blakesley Conchotome
07:16

Human Vastus Lateralis Skeletal Muscle Biopsy Using the Weil-Blakesley Conchotome

Published on: March 4, 2016

16.6K

Related Experiment Videos

Last Updated: May 21, 2025

Human Skeletal Muscle Biopsy Procedures Using the Modified Bergström Technique
07:20

Human Skeletal Muscle Biopsy Procedures Using the Modified Bergström Technique

Published on: September 10, 2014

39.9K
A Guide to Examining Intramuscular Fat Formation and its Cellular Origin in Skeletal Muscle
09:19

A Guide to Examining Intramuscular Fat Formation and its Cellular Origin in Skeletal Muscle

Published on: May 26, 2022

3.8K
Human Vastus Lateralis Skeletal Muscle Biopsy Using the Weil-Blakesley Conchotome
07:16

Human Vastus Lateralis Skeletal Muscle Biopsy Using the Weil-Blakesley Conchotome

Published on: March 4, 2016

16.6K

Area of Science:

  • Hepatology
  • Cardiology
  • Metabolic Disorders

Background:

  • Metabolic-associated steatotic liver disease (MASLD), previously nonalcoholic fatty liver disease, is a global health concern linked to cardiovascular disease (CVD).
  • Lean MASLD, characterized by hepatic steatosis and cardiometabolic risk factors in normal-weight individuals, presents a paradox of elevated cardiovascular risk compared to nonlean MASLD.
  • Distinct metabolic, genetic, and microbiome profiles in lean MASLD contribute to visceral adiposity, sarcopenia, fibrosis, inflammation, and endothelial dysfunction.

Purpose of the Study:

  • To review the epidemiology, pathophysiology, and cardiovascular outcomes of lean MASLD.
  • To address existing discrepancies in the literature regarding lean MASLD and cardiovascular risk.
  • To highlight current clinical guidelines, lifestyle modifications, and emerging pharmacotherapies for lean MASLD.

Main Methods:

  • Literature review of epidemiological data.
  • Analysis of pathophysiological mechanisms.
  • Examination of clinical guidelines and emerging treatments.

Main Results:

  • Lean MASLD is associated with increased visceral adiposity, sarcopenia, hepatic fibrosis, systemic inflammation, and endothelial dysfunction.
  • Studies suggest lean MASLD may confer a higher cardiovascular risk than nonlean MASLD.
  • Distinctive patient profiles contribute to varied disease progression and outcomes.

Conclusions:

  • Lean MASLD represents a critical subgroup with significant cardiovascular implications requiring targeted research and clinical attention.
  • Understanding the unique pathophysiology of lean MASLD is crucial for developing effective management strategies.
  • Lifestyle modifications and novel pharmacotherapies hold promise for improving cardiovascular outcomes in lean MASLD patients.